If the medication is stopped, weight and metabolic risk factors often return, so the benefits may diminish
Public Health Recommendations The CPHA article outlines three recommendations for the public health sector: Addressing industry influence and the commercial determinants of health, including engagement in policy reform around drug pricing, regulation, and access Strengthening evidence and surveillance to track GLP-1 use, access, outcomes, and inequities Countering misinformation through knowledge translation and health education initiatives The author writes that long-term effectiveness of GLP-1 drugs in everyday use remains uncertain, including whether changes are sustained and what happens after stopping treatment
Tirzepatide has not been studied in people with more advanced forms of diabetic retinopathy
To help you trust the information we provide, every article written by Nuvo Wellness and Health relies on peer-reviewed studies and medically reviewed facts
Glycemic improvements often occur more rapidly, with measurable hemoglobin A1c reductions within 4-8 weeks
Can PT-141 Be Combined with Other Medications